Literature DB >> 33966344

Experimental liver models: From cell culture techniques to microfluidic organs-on-chip.

Michela Anna Polidoro1, Erika Ferrari2, Simona Marzorati1, Ana Lleo3,4, Marco Rasponi2.   

Abstract

The liver is one of the most studied organs of the human body owing to its central role in xenobiotic and drug metabolism. In recent decades, extensive research has aimed at developing in vitro liver models able to mimic liver functions to study pathophysiological clues in high-throughput and reproducible environments. Two-dimensional (2D) models have been widely used in screening potential toxic compounds but have failed to accurately reproduce the three-dimensionality (3D) of the liver milieu. To overcome these limitations, improved 3D culture techniques have been developed to recapitulate the hepatic native microenvironment. These models focus on reproducing the liver architecture, representing both parenchymal and nonparenchymal cells, as well as cell interactions. More recently, Liver-on-Chip (LoC) models have been developed with the aim of providing physiological fluid flow and thus achieving essential hepatic functions. Given their unprecedented ability to recapitulate critical features of the liver cellular environments, LoC have been extensively adopted in pathophysiological modelling and currently represent a promising tool for tissue engineering and drug screening applications. In this review, we discuss the evolution of experimental liver models, from the ancient 2D hepatocyte models, widely used for liver toxicity screening, to 3D and LoC culture strategies adopted for mirroring a more physiological microenvironment for the study of liver diseases.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  2D cell culture; 3D spheroids; hepatocytes; liver; liver-on-chip

Year:  2021        PMID: 33966344     DOI: 10.1111/liv.14942

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  6 in total

1.  Comparison of Hydrogen Peroxide Secretion From Living Cells Cultured in Different Formats Using Hydrogel-Based LSPR Substrates.

Authors:  Yang-Jyun Siao; Chien-Chung Peng; Yi-Chung Tung; Yih-Fan Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-04-08

2.  Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver's Extracellular Matrix.

Authors:  Taha Messelmani; Anne Le Goff; Zied Souguir; Victoria Maes; Méryl Roudaut; Elodie Vandenhaute; Nathalie Maubon; Cécile Legallais; Eric Leclerc; Rachid Jellali
Journal:  Bioengineering (Basel)       Date:  2022-09-05

Review 3.  Advancements in the Alcohol-Associated Liver Disease Model.

Authors:  Lin Zhu; Hai-Di Li; Jie-Jie Xu; Juan-Juan Li; Miao Cheng; Xiao-Ming Meng; Cheng Huang; Jun Li
Journal:  Biomolecules       Date:  2022-07-27

Review 4.  Advances in the application of 3D tumor models in precision oncology and drug screening.

Authors:  Xiaoyong Guan; Shigao Huang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-28

5.  A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors.

Authors:  Petko Alov; Merilin Al Sharif; Denitsa Aluani; Konstantin Chegaev; Jelena Dinic; Aleksandra Divac Rankov; Miguel X Fernandes; Fabio Fusi; Alfonso T García-Sosa; Risto Juvonen; Magdalena Kondeva-Burdina; José M Padrón; Ilza Pajeva; Tania Pencheva; Adrián Puerta; Hannu Raunio; Chiara Riganti; Ivanka Tsakovska; Virginia Tzankova; Yordan Yordanov; Simona Saponara
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

Review 6.  From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights.

Authors:  Alexandra Gatzios; Matthias Rombaut; Karolien Buyl; Joery De Kock; Robim M Rodrigues; Vera Rogiers; Tamara Vanhaecke; Joost Boeckmans
Journal:  Biomedicines       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.